RNAM
Avidity Biosciences·NASDAQ
--
--(--)
--
--(--)
RNAM fundamentals
Avidity Biosciences (RNAM) released its earnings on Nov 10, 2025: revenue was 12.50M (YoY +435.10%), beat estimates; EPS was -1.27 (YoY -95.38%), missed estimates.
Revenue / YoY
12.50M
+435.10%
EPS / YoY
-1.27
-95.38%
Report date
Nov 10, 2025
EPS
Revenue
Revenue & Expenses
RNAM has released its 2025 Q4 earnings report, with revenue of 860.00K, reflecting a YoY change of -71.07%, and net profit of -237.10M, showing a YoY change of -131.87%. The Sankey diagram below clearly presents RNAM's revenue sources and cost distribution.
Key Indicators
Avidity Biosciences (RNAM) key financial stats and ratios, covering profitability, financial health, and leverage.
Avidity Biosciences (RNAM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Avidity Biosciences (RNAM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Avidity Biosciences (RNAM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Avidity Biosciences (RNAM) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Avidity Biosciences (RNAM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Avidity Biosciences year over year?What is Avidity Biosciences's gross profit margin?Did Avidity Biosciences beat or miss consensus estimates last quarter?What is Avidity Biosciences's latest dividend and current dividend yield?What were the key takeaways from Avidity Biosciences's earnings call?What does Avidity Biosciences do and what are its main business segments?What factors drove the changes in Avidity Biosciences's revenue and profit?What were the key takeaways from Avidity Biosciences’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
